Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrarapid 15-minute iron polymaltose infusion for iron deficiency anaemia
ACTRN12619000272190Phase 4Completed
- Sponsor
- Iouri Banakh
- Start
- Jun 2019
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of iron polymaltose in iron deficiency anemia (IDA), sponsored by Iouri Banakh. Primary endpoint: Overall adverse event rate during infusion. Started Jun 2019; status: completed.
02
Drugs
iron polymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on ACTRN12619000272190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619000272190.